SBI Securities predicts a bullish technical breakout for Aurobindo Pharma and Union Bank of India.

1 report, 1 independent Updated Aug 9

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Aurobindo Pharma Union Bank of India

Keep exploring

Part of

Market updates regarding Hindalco Industries, SIS, Aurobindo Pharma, and Bayer CropScience were reported in Mumbai starting August 1, 2026. All 1 developments

The entities involved

Aurobindo Pharma
an Indian pharmaceutical company
- MSD and Aurobindo Pharma signed a voluntary licensing agreement for generic alimatravir.Mon 05:30
Union Bank of India
Indian government-owned banking company
- Insolvency proceedings have been initiated against Union Bank of India regarding a Rs 432-crore default, involving a revival process and intervention by the Supreme Court.Sun 23:54

Related events

Indian market performance reflects global trends.Sep 11

Coverage

Newest first; wire copies grouped

Aug 9moneycontrol.com